Oak Ridge Investments’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-137,819
Closed -$20.1M 171
2017
Q3
$20.1M Sell
137,819
-20,178
-13% -$2.75M 0.82% 51
2017
Q2
$20.5M Buy
157,997
+6,412
+4% +$786K 0.65% 61
2017
Q1
$18.9M Buy
151,585
+17,075
+13% +$2.04M 0.63% 63
2016
Q4
$15.6M Sell
134,510
-50,269
-27% -$5.6M 0.5% 59
2016
Q3
$19.3M Sell
184,779
-2,914
-2% -$315K 0.5% 66
2016
Q2
$18.5M Sell
187,693
-10,562
-5% -$1.09M 0.48% 65
2016
Q1
$19.8M Buy
198,255
+14,527
+8% +$1.5M 0.5% 63
2015
Q4
$22M Buy
183,728
+1,004
+0.5% +$116K 0.53% 60
2015
Q3
$19.8M Buy
182,724
+552
+0.3% +$68.5K 0.47% 60
2015
Q2
$21.1M Buy
182,172
+275
+0.2% +$31.4K 0.45% 64
2015
Q1
$21M Sell
181,897
-145,642
-44% -$17.4M 0.47% 64
2014
Q4
$36.6M Sell
327,539
-11,521
-3% -$1.22M 0.87% 46
2014
Q3
$32.1M Sell
339,060
-31,416
-8% -$2.84M 0.84% 44
2014
Q2
$31.9M Buy
370,476
+27,910
+8% +$2.12M 0.76% 50
2014
Q1
$23.9M Sell
342,566
-4,404
-1% -$349K 0.6% 58
2013
Q4
$29.3M Sell
346,970
-9,900
-3% -$783K 0.77% 51
2013
Q3
$27.5M Sell
356,870
-3,854
-1% -$270K 0.76% 51
2013
Q2
$21.1M Buy
+360,724
New +$21.7M 0.66% 55

Other funds holding CELG

Oak Ridge Investments's CELG Position: Q4 2017 in Review

Oak Ridge Investments sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 137,819 shares — an estimated $20.1M sold.

Oak Ridge Investments first reported a position in CELG in Q2 2013 and held it in 18 quarters. The position peaked at $36.6M in Q4 2014. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Oak Ridge Investments reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Oak Ridge Investments sold 137,819 Celgene Corp shares in Q4 2017, an estimated $20.1M.
  • Oak Ridge Investments first reported a position in Celgene Corp in Q2 2013 and held it in 18 quarters.
  • Oak Ridge Investments's Celgene Corp position peaked at $36.6M in Q4 2014.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Oak Ridge Investments's 13F filing for Q4 2017, filed 13 Feb 2018.